Remarkably, our research has shown that reducing the expression of CD155 significantly enhanced IFN-γ production in CD8+ T cells and their cytotoxicity against colorectal cancer cells, leading to a marked reduction in radioresistant tumor volume. The gene discussed is CD8A; the disease is neoplasm.